Journal
NEUROCHEMICAL RESEARCH
Volume 43, Issue 7, Pages 1424-1438Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11064-018-2558-z
Keywords
PTEN; BpV(pic); Cerebral ischemia; AKT; ERK 1/2
Categories
Funding
- China Key Project of Basic Research (973 Project) [2014CB541606]
- Natural Science Foundation of China (NSFC) [81470599]
- Collaborative Innovation Center for Brain Science
Ask authors/readers for more resources
Bisperoxovanadium (pyridine-2-carboxyl) [bpV(pic)] is a commercially available PTEN inhibitor. Previous studies from us and others have shown that bpV(pic) confers neuroprotection in cerebral ischemia injury. We set up to determine whether ERK 1/2 activation plays a role in bpV(pic)-induced neuroprotective effect in cerebral ischemia injury. We found that the phosphorylation levels of Akt (p-AKT) and ERK1/2 (p-ERK 1/2) were down-regulated after cerebral ischemia-reperfusion injury. The injection of bpV(pic) after injury not only increased the level of p-AKT but also the level of p-ERK 1/2. While the inhibition of PTEN mediated the up-regulatation of p-AKT and p-ERK 1/2 by bpV(pic). Interestingly, the ERK 1/2 activation induced by bpV(pic) was also independent of the inhibition of PTEN. Our results indicate that bpV(pic) protects against OGD-induced neuronal death and promotes the functional recovery of stroke animals through PTEN inhibition and ERK 1/2 activation, respectively. This study suggests that the effect of bpV(pic) on ERK 1/2 signaling should be considered while using bpV(pic) as a PTEN inhibitor.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available